99 related articles for article (PubMed ID: 15163197)
1. Synthesis and structure-activity relationships of a novel series of tricyclic dihydropyridine-based KATP openers that potently inhibit bladder contractions in vitro.
Carroll WA; Agrios KA; Altenbach RJ; Buckner SA; Chen Y; Coghlan MJ; Daza AV; Drizin I; Gopalakrishnan M; Henry RF; Kort ME; Kym PR; Milicic I; Smith JC; Tang R; Turner SC; Whiteaker KL; Zhang H; Sullivan JP
J Med Chem; 2004 Jun; 47(12):3180-92. PubMed ID: 15163197
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a potent K(ATP) opener that selectively inhibits spontaneous bladder contractions.
Carroll WA; Altenbach RJ; Bai H; Brioni JD; Brune ME; Buckner SA; Cassidy C; Chen Y; Coghlan MJ; Daza AV; Drizin I; Fey TA; Fitzgerald M; Gopalakrishnan M; Gregg RJ; Henry RF; Holladay MW; King LL; Kort ME; Kym PR; Milicic I; Tang R; Turner SC; Whiteaker KL; Yi L; Zhang H; Sullivan JP
J Med Chem; 2004 Jun; 47(12):3163-79. PubMed ID: 15163196
[TBL] [Abstract][Full Text] [Related]
3. Effects of substitution on 9-(3-bromo-4-fluorophenyl)-5,9-dihydro-3H,4H-2,6-dioxa-4- azacyclopenta[b]naphthalene-1,8-dione, a dihydropyridine ATP-sensitive potassium channel opener.
Altenbach RJ; Brune ME; Buckner SA; Coghlan MJ; Daza AV; Fabiyi A; Gopalakrishnan M; Henry RF; Khilevich A; Kort ME; Milicic I; Scott VE; Smith JC; Whiteaker KL; Carroll WA
J Med Chem; 2006 Nov; 49(23):6869-87. PubMed ID: 17154517
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of urinary bladder smooth muscle contractility following partial bladder outlet obstruction in pigs.
Milicic I; Buckner SA; Daza A; Coghlan M; Fey TA; Brune ME; Gopalakrishnan M
Eur J Pharmacol; 2006 Feb; 532(1-2):107-14. PubMed ID: 16487510
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous phasic activity of the pig urinary bladder smooth muscle: characteristics and sensitivity to potassium channel modulators.
Buckner SA; Milicic I; Daza AV; Coghlan MJ; Gopalakrishnan M
Br J Pharmacol; 2002 Feb; 135(3):639-48. PubMed ID: 11834611
[TBL] [Abstract][Full Text] [Related]
6. [125I]A-312110, a novel high-affinity 1,4-dihydropyridine ATP-sensitive K+ channel opener: characterization and pharmacology of binding.
Davis-Taber R; Molinari EJ; Altenbach RJ; Whiteaker KL; Shieh CC; Rotert G; Buckner SA; Malysz J; Milicic I; McDermott JS; Gintant GA; Coghlan MJ; Carroll WA; Scott VE; Gopalakrishnan M
Mol Pharmacol; 2003 Jul; 64(1):143-53. PubMed ID: 12815170
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity studies of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladder.
Perez-Medrano A; Brune ME; Buckner SA; Coghlan MJ; Fey TA; Gopalakrishnan M; Gregg RJ; Kort ME; Scott VE; Sullivan JP; Whiteaker KL; Carroll WA
J Med Chem; 2007 Nov; 50(24):6265-73. PubMed ID: 17973362
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the potassium channel openers, WAY-133537, ZD6169, and celikalim on isolated bladder tissue and In vivo bladder instability in rat.
Wojdan A; Freeden C; Woods M; Oshiro G; Spinelli W; Colatsky TJ; Sheldon JH; Norton NW; Warga D; Antane MM; Antane SA; Butera JA; Argentieri TM
J Pharmacol Exp Ther; 1999 Jun; 289(3):1410-8. PubMed ID: 10336534
[TBL] [Abstract][Full Text] [Related]
9. Functional implication of spare ATP-sensitive K(+) channels in bladder smooth muscle cells.
Shieh CC; Feng J; Buckner SA; Brioni JD; Coghlan MJ; Sullivan JP; Gopalakrishnan M
J Pharmacol Exp Ther; 2001 Mar; 296(3):669-75. PubMed ID: 11181891
[TBL] [Abstract][Full Text] [Related]
10. Structure-Activity studies for a novel series of tricyclic dihydropyrimidines as K(ATP) channel openers (KCOs).
Drizin I; Holladay MW; Yi L; Zhang HQ; Gopalakrishnan S; Gopalakrishnan M; Whiteaker KL; Buckner SA; Sullivan JP; Carroll WA
Bioorg Med Chem Lett; 2002 Jun; 12(11):1481-4. PubMed ID: 12031324
[TBL] [Abstract][Full Text] [Related]
11. Effects of ATP-sensitive K+ channel openers and tolterodine on involuntary bladder contractions in a pig model of partial bladder outlet obstruction.
Fey TA; Gopalakrishnan M; Strake JG; King LL; Brioni JD; Sullivan JP; Coghlan MJ; Brune ME
Neurourol Urodyn; 2003; 22(2):147-55. PubMed ID: 12579633
[TBL] [Abstract][Full Text] [Related]
12. Discovery and structure-activity relationships of a novel series of benzopyran-based K(ATP) openers for urge urinary incontinence.
Zhang X; Qiu Y; Li X; Bhattacharjee S; Woods M; Kraft P; Lundeen SG; Sui Z
Bioorg Med Chem; 2009 Jan; 17(2):855-66. PubMed ID: 19101153
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and calcium channel-modulating effects of alkyl (or cycloalkyl) 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridyl-5-pyridinecarboxylate racemates and enantiomers.
Ramesh M; Matowe WC; Akula MR; Vo D; Dagnino L; Li-Kwong-Ken MC; Wolowyk MW; Knaus EE
J Med Chem; 1998 Feb; 41(4):509-14. PubMed ID: 9484501
[TBL] [Abstract][Full Text] [Related]
14. Effects of potassium channel modulators on human detrusor smooth muscle myogenic phasic contractile activity: potential therapeutic targets for overactive bladder.
Darblade B; Behr-Roussel D; Oger S; Hieble JP; Lebret T; Gorny D; Benoit G; Alexandre L; Giuliano F
Urology; 2006 Aug; 68(2):442-8. PubMed ID: 16904481
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous contractions of the pig urinary bladder: the effect of ATP-sensitive potassium channels and the role of the mucosa.
Akino H; Chapple CR; McKay N; Cross RL; Murakami S; Yokoyama O; Chess-Williams R; Sellers DJ
BJU Int; 2008 Nov; 102(9):1168-74. PubMed ID: 18647302
[TBL] [Abstract][Full Text] [Related]
16. (-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. II. in vivo characterization.
Brune ME; Fey TA; Brioni JD; Sullivan JP; Williams M; Carroll WA; Coghlan MJ; Gopalakrishnan M
J Pharmacol Exp Ther; 2002 Oct; 303(1):387-94. PubMed ID: 12235275
[TBL] [Abstract][Full Text] [Related]
17. N-aryl-3,3,3-trifluoro-2-hydroxy-2-methylpropanamides: KATP potassium channel openers. Modifications on the western region.
Ohnmacht CJ; Russell K; Empfield JR; Frank CA; Gibson KH; Mayhugh DR; McLaren FM; Shapiro HS; Brown FJ; Trainor DA; Ceccarelli C; Lin MM; Masek BB; Forst JM; Harris RJ; Hulsizer JM; Lewis JJ; Silverman SM; Smith RW; Warwick PJ; Kau ST; Chun AL; Grant TL; Howe BB; Neilson KL
J Med Chem; 1996 Nov; 39(23):4592-601. PubMed ID: 8917648
[TBL] [Abstract][Full Text] [Related]
18. Zeneca ZD6169 and its analogs from a novel series of anilide tertiary carbinols: in vitro KATP channel opening activity in bladder detrusor.
Li JH; Yasay GD; Zografos P; Kau ST; Ohnmacht CJ; Russell K; Empfield JR; Brown FJ; Trainor DA; Bonev AD
Pharmacology; 1995 Jun; 51(1):33-42. PubMed ID: 7568342
[TBL] [Abstract][Full Text] [Related]
19. Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 1. N-Cyanoguanidine bioisosteres possessing in vivo bladder selectivity.
Butera JA; Antane MM; Antane SA; Argentieri TM; Freeden C; Graceffa RF; Hirth BH; Jenkins D; Lennox JR; Matelan E; Norton NW; Quagliato D; Sheldon JH; Spinelli W; Warga D; Wojdan A; Woods M
J Med Chem; 2000 Mar; 43(6):1187-202. PubMed ID: 10737752
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity studies for a novel series of tricyclic dihydropyridopyrazolones and dihydropyridoisoxazolones as K(ATP) channel openers.
Drizin I; Altenbach RJ; Buckner SA; Whiteaker KL; Scott VE; Darbyshire JF; Jayanti V; Henry RF; Coghlan MJ; Gopalakrishnan M; Carroll WA
Bioorg Med Chem; 2004 Apr; 12(8):1895-904. PubMed ID: 15051058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
